ARX vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

56MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

ARX MVP
Technical
48
68
Catalyst
55
50
Sentiment
50
50
Fundamental
99
95
Momentum
46
51
Risk Gate
50
50

Key Metrics

ARX Metric MVP
$191.1MMarket Cap$52.9M
144KAvg Volume (20d)214K
N/AShort InterestN/A
$0.80052-Week High$0.765
$0.49552-Week Low$0.365
+0.0%Daily Change+2.2%
$0.540Reference Price$0.460
+4.9%ROE+1.1%
+4.5%Profit Margin+1.5%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 4.4% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ARX and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ATX vs CUV →ATX vs MVP →BLS vs CUV →BLS vs MVP →CGS vs IMM →
ARX Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).